ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
NeuExcell Therapeutics and Spark Therapeutics Announce Research Collaboration Agreement to Develop a Novel Gene Therapy for Huntington's Disease
September 13, 2021OTCQX: RHHBY) today announced a gene therapy collaboration aimed at developing a safe and effective treatment for patients suffering from Huntington's Disease (HD). -
PTC Therapeutics Announces Trial for Huntington's Disease
December 01, 2020PTC Therapeutics announced the initiation of a Phase 1 clinical trial to evaluate PTC518 in healthy volunteers. PTC518 was identified from PTC's splicing platform and is being developed for the treatment of Huntington's disease (HD). -
A drug lowers Huntington’s disease protein for the first time
December 18, 2017This is the first time the protein known to cause Huntington’s has been lowered in the nervous system of patients.
Pharma Sources Insight January 2025
